Symptomatic Care in Multiple System Atrophy: State of the Art

Cerebellum. 2023 Jun;22(3):433-446. doi: 10.1007/s12311-022-01411-6. Epub 2022 May 17.

Abstract

Without any disease-modifying treatment strategy for multiple system atrophy (MSA), the therapeutic management of MSA patients focuses on a multidisciplinary strategy of symptom control. In the present review, we will focus on state of the art treatment in MSA and additionally give a short overview about ongoing randomized controlled trials in this field.

Keywords: Autonomic dysfunction; Motor and non-motor symptoms; Multiple system atrophy; Symptomatic treatment.

Publication types

  • Review

MeSH terms

  • Humans
  • Longitudinal Studies
  • Multiple System Atrophy* / diagnosis